Oligomenorrhea. Secondary Oligomenorrhoea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: 20-40 y/o women; willing to participate in the study; cessation of menstrual bleeding for more than 14 days that has been repeated for at least 3 episodes during the last year; negative pregnancy test; not in lactation period; not affected by: diabetes, hypertension, organic disease and malignancies, chronic disease of the liver and kidneys; not using any kind of hormonal drugs(e.g. OCP) Exclusion criteria: Using hormonal drugs or any drug that will affect menstruation during the treatment period; patients willing to exit the study; patients that need invasive treatments during the study Exclusion criteria: Using hormonal drugs during the study experiencing drugs side effects patients who need interventions like surgery procedures those who will to exit the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual bleeding initiation. Timepoint: 2 weeks and 4 weeks after finishing the drug consumption. Method of measurement: interview.;Waiting period before menstrual bleeding. Timepoint: 2 weeks after finish the drug consumption. Method of measurement: interview. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight gain. Timepoint: during the study. Method of measurement: interview.;Hyrsutism. Timepoint: during the study. Method of measurement: interview.;Acne. Timepoint: during the study. Method of measurement: interview.;Nausia. Timepoint: during the study. Method of measurement: interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Faculty of Traditional Medicine, Shahid Beheshty University of Medical Sciences